
By BY ERIN GRIFFITH
Defense lawyers are expected to argue that the founder of Theranos, the blood-testing start-up, failed but did not commit fraud.
Published: November 19, 2021 at 12:34PM
from NYT Technology https://ift.tt/30FJL4K
via IFTTT

By BY ERIN GRIFFITH
Defense lawyers are expected to argue that the founder of Theranos, the blood-testing start-up, failed but did not commit fraud.
Published: November 19, 2021 at 12:34PM
from NYT Technology https://ift.tt/30FJL4K
via IFTTT